Published • loading... • Updated
It’s the elephant in the jockeys’ room. Is it time WADA banned Ozempic?
WADA examines semaglutide's health risks and potential performance effects in weight-sensitive sports as 40% of weight loss from these drugs is fat-free mass, experts say.
Summary by Sydney Morning Herald
3 Articles
3 Articles
Coverage Details
Total News Sources3
Leaning Left2Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium



